P987: A DIFFERENT BALANCE IN OXIDATIVE STRESS RESPONSE IN CALR AND JAK2 MUTATED MYELOFIBROSIS PATIENTS CORRELATES WITH CLINICAL OUTCOME

P987: A DIFFERENT BALANCE IN OXIDATIVE STRESS RESPONSE IN CALR AND JAK2 MUTATED MYELOFIBROSIS PATIENTS CORRELATES WITH CLINICAL OUTCOME

Bibliographic Details
Main Authors:	E. Genovese, M. Mirabile, S. Rontauroli, S. Sartini, S. Fantini, L. Tavernari, M. Maccaferri, P. Guglielmelli, E. Bianchi, S. Parenti, C. Carretta, S. Mallia, S. Castellano, C. Colasante, M. Balliu, N. Bartalucci, R. Palmieri, T. Ottone, B. Mora, L. Potenza, F. Passamonti, M. T. Voso, M. Luppi, A. M. Vannucchi, E. Tagliafico, R. Manfredini
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846816.99441.01

Similar Items

P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
by: L. Tavernari, et al.
Published: (2022-06-01)

The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
by: Elena Genovese, et al.
Published: (2022-01-01)

P1000: INCREASED PLASMA LEVELS OF LNCRNAS ARE POTENTIAL PROGNOSTIC BIOMARKERS IN MYELOFIBROSIS
by: S. Sartini, et al.
Published: (2022-06-01)

P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
by: S. Rontauroli, et al.
Published: (2022-06-01)

P983: SINGLE CELL ANALYSIS ALLOWS THE EARLY DETECTION OF LEUKEMIC CLONES IN MPN PATIENTS
by: C. Carretta, et al.
Published: (2022-06-01)

Genomic Analysis of Hematopoietic Stem Cell at the Single-Cell Level: Optimization of Cell Fixation and Whole Genome Amplification (WGA) Protocol
by: Chiara Carretta, et al.
Published: (2020-10-01)

Increased Plasma Levels of lncRNAs <i>LINC01268</i>, <i>GAS5</i> and <i>MALAT1</i> Correlate with Negative Prognostic Factors in Myelofibrosis
by: Sebastian Fantini, et al.
Published: (2021-09-01)

Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis
by: Paola Guglielmelli, et al.
Published: (2023-01-01)

Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
by: Sandra Parenti, et al.
Published: (2021-02-01)

Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective
by: Sebastiano Rontauroli, et al.
Published: (2022-12-01)

CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS
by: E. G. lisina, et al.
Published: (2017-10-01)

Ruxolitinib for CALR-positive Myelofibrosis: A Case Report and Literature Review
by: GUO Huimei, et al.
Published: (2018-08-01)

CALR Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim
Published: (2014-06-01)

Pleomorphic circulating megakaryocytes in a case of CALR positive primary myelofibrosis in leukemic transformation
by: Habib Moshref Razavi
Published: (2021-11-01)

Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
by: Federico Lussana, et al.
Published: (2017-02-01)

Development of paroxysmal nocturnal hemoglobinuria in CALR-positive myeloproliferative neoplasm
by: Fraiman YS, et al.
Published: (2016-05-01)

Application of heteroduplex analysis for CALR mutation screening detection in patients with Ph-myeloproliferative neoplasms
by: T. N. Subbotina, et al.
Published: (2021-06-01)

PB2061: A RARE CASE OF CALR MUTATION IN JAK2-NEGATIVE PATIENT WITH POLYCYTHEMIA
by: T. Subbotina, et al.
Published: (2022-06-01)

The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms
by: Tanja Belčič Mikič, et al.
Published: (2021-03-01)

Bioinformatics analysis for the role of CALR in human cancers.
by: Yijun Li, et al.
Published: (2021-01-01)

FREQUENCY OF CALR GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Sana Latif, et al.
Published: (2020-04-01)

Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post‐essential thrombocythemia myelofibrosis: A case report
by: Mahija Cheekati, et al.
Published: (2024-04-01)

Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development.
by: Balligand, T, et al.
Published: (2019)

A case of <i>CALR</i> mutation in <i>JAK2</i>-negative patient with polycythemia
by: T. N. Subbotina, et al.
Published: (2022-04-01)

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report
by: Gurban, P, et al.
Published: (2023)

Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report
by: E Morsia, et al.
Published: (2021-01-01)

Analysis of somatic mutations in the <i>JAK2</i>, <i>CALR</i>, <i>MPL</i> and <i>ASXL1</i> genes and evaluation of their impact on the survival of patients with myelofibrosis
by: T. N. Subbotina, et al.
Published: (2023-03-01)

Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant
by: Ayalew Tefferi, et al.
Published: (2024-03-01)

CALR-ETdb, the database of calreticulin variants diversity in essential thrombocythemia
by: Nora El Jahrani, et al.
Published: (2022-01-01)

VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
by: Laura Villani, et al.
Published: (2021-10-01)

The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia
by: S. Travaglini, et al.
Published: (2022-07-01)

Comparison of molecular genetic methods of detection of mutations in the CALR gene in myeloproliferative disorders
by: L. A. Kesaeva, et al.
Published: (2019-07-01)

Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice
by: Keiji Minakawa, et al.
Published: (2021-03-01)

Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
by: Simone Romagnoli, et al.
Published: (2021-11-01)

Characterization of New <i>ATM</i> Deletion Associated with Hereditary Breast Cancer
by: Sandra Parenti, et al.
Published: (2021-01-01)

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis
by: Lasse Kjær, et al.
Published: (2023-05-01)

Art in mediaeval France, 987-1498 /
by: 191394 Evans, Joan
Published: (1948)

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report
by: Petruta Gurban, et al.
Published: (2023-09-01)

Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.
by: Paola Guglielmelli, et al.
Published: (2015-01-01)

The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis
by: Yuxia Pan, et al.
Published: (2022-12-01)